219 related articles for article (PubMed ID: 19545926)
1. Hepatitis C virus-induced hepatocarcinogenesis.
Bartosch B; Thimme R; Blum HE; Zoulim F
J Hepatol; 2009 Oct; 51(4):810-20. PubMed ID: 19545926
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
Koike K
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.
Yamashita T; Honda M; Kaneko S
J Gastroenterol Hepatol; 2011 Jun; 26(6):960-4. PubMed ID: 21443660
[TBL] [Abstract][Full Text] [Related]
4. Viral hepatitis and liver cancer: the case of hepatitis C.
Levrero M
Oncogene; 2006 Jun; 25(27):3834-47. PubMed ID: 16799625
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus and hepatocellular carcinoma.
Colombo M
Semin Liver Dis; 1999; 19(3):263-9. PubMed ID: 10518306
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.
Amin MA; Awadein MR; Gabr H
Chin J Dig Dis; 2005; 6(3):142-8. PubMed ID: 16045605
[TBL] [Abstract][Full Text] [Related]
7. Molecular viral oncology of hepatocellular carcinoma.
Block TM; Mehta AS; Fimmel CJ; Jordan R
Oncogene; 2003 Aug; 22(33):5093-107. PubMed ID: 12910247
[TBL] [Abstract][Full Text] [Related]
8. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Marotta F; Vangieri B; Cecere A; Gattoni A
Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
[TBL] [Abstract][Full Text] [Related]
9. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
Nada O; Abdel-Hamid M; Ismail A; El Shabrawy L; Sidhom KF; El Badawy NM; Ghazal FA; El Daly M; El Kafrawy S; Esmat G; Loffredo CA
J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
[TBL] [Abstract][Full Text] [Related]
10. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis.
Raimondi S; Bruno S; Mondelli MU; Maisonneuve P
J Hepatol; 2009 Jun; 50(6):1142-54. PubMed ID: 19395111
[TBL] [Abstract][Full Text] [Related]
12. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
13. [HCV core gene transgenic mouse as a model for viral hepatocarcinogenesis].
Koike K
Nihon Rinsho; 2001 Jul; 59(7):1265-70. PubMed ID: 11494535
[TBL] [Abstract][Full Text] [Related]
14. Risk of hepatocellular carcinoma and secondary structure of hepatitis C virus (HCV) NS3 protein amino-terminus, in patients infected with HCV subtype 1b.
Nishise Y; Saito T; Sugahara K; Ito JI; Saito K; Togashi H; Nagano-Fujii M; Hotta H; Kawata S
J Infect Dis; 2007 Oct; 196(7):1006-9. PubMed ID: 17763321
[TBL] [Abstract][Full Text] [Related]
15. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
[TBL] [Abstract][Full Text] [Related]
16. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma.
Feitelson MA
Cancer Lett; 2006 Jul; 239(1):10-20. PubMed ID: 16154256
[TBL] [Abstract][Full Text] [Related]
17. The oncogenic role of hepatitis C virus.
Koike K
Recent Results Cancer Res; 2014; 193():97-111. PubMed ID: 24008295
[TBL] [Abstract][Full Text] [Related]
18. Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.
Hamada H; Yatsuhashi H; Yano K; Daikoku M; Arisawa K; Inoue O; Koga M; Nakata K; Eguchi K; Yano M
Cancer; 2002 Jul; 95(2):331-9. PubMed ID: 12124834
[TBL] [Abstract][Full Text] [Related]
19. Malignancies associated with chronic hepatitis C: case report and review of the literature.
Vlaar AP; Rietdijk ST; Zeerleder SS; Boerman T; Beuers U
Neth J Med; 2011 May; 69(5):211-5. PubMed ID: 21646667
[TBL] [Abstract][Full Text] [Related]
20. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
